Interview with Sam Cobb, Founder CEO and Director of AdAlta (Swings & Roundabouts ep. 038)
Tuesday, May 9, 2017 1:00 AM +00:00
Interview with Sam Cobb, Founder CEO and Dire...0:0011:45LIVEQuality1 AudioSubtitleDownloadSpeed1
SWINGS & ROUNDABOUTS
An Australian Biotech company developing a unique platform based around human antibodies that aims to drug previously un-druggable targets, with the first indication Idiopathic Pulmonary Fibrosis or IPF.